Hemanext Partners with Sickle Cell 101 to Sponsor Sickle Cell ...
- Written by LATEST ASIANET NEWS RELEASES
- Published in Asia Net
LEXINGTON, Mass. and SAN FRANCISCO, July 29, 2021 /PRNewswire-AsiaNet/ -- -- Sickle Cell Disease (SCD) Affects Over 20M Worldwide, including 100K Americans[1],[2] Hemanext Inc. a privately held, US-based medical technology company dedicated to improving the quality, safety, efficacy, and cost of red blood cell (RBC)...
Authors: LATEST ASIANET NEWS RELEASES